Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase Lck.

Abstract:

:Dexamethasone (DM) is a synthetic member of the glucocorticoid (GC) class of hormones that possesses anti-inflammatory and immunosuppressant activity and is commonly used to treat chronic inflammatory disorders, severe allergies, and other disease states. Although GCs are known to mediate well-defined transcriptional effects via GC receptors (GCR), there is increasing evidence that GCs also initiate rapid nongenomic signaling events in a variety of cell types. Here, we report that DM induces the phosphorylation of Lck and the activation of other downstream mediators, including p59Fyn, Zap70, Rac1, and Vav in resting but not activated human T cells. DM treatment also augments CXCL12-mediated signaling in resting T cells through its cell surface receptor, CXCR4 resulting in the enhanced actin polymerization, Rac activation, and cell migration on ligand exposure. Lck was found to be a critical intermediate in these DM-induced signaling activities. Moreover, DM-mediated Lck phosphorylation in T cells was dependent on the presence of both the GCR and the CD45 molecule. Overall, these results elucidate additional nongenomic effects of DM and the GCR on resting human T cells, inducing Lck and downstream kinase activation and augmenting chemokine signaling and function.

journal_name

Blood

journal_title

Blood

authors

Ghosh MC,Baatar D,Collins G,Carter A,Indig F,Biragyn A,Taub DD

doi

10.1182/blood-2008-04-151803

subject

Has Abstract

pub_date

2009-01-15 00:00:00

pages

575-84

issue

3

eissn

0006-4971

issn

1528-0020

pii

blood-2008-04-151803

journal_volume

113

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Dangerous small B-cell clones.

    abstract::The detection of a monoclonal immunoglobulin in serum or urine usually raises concerns about the size of the underlying B-cell-derived clone and possible systemic effects caused by its expansion. However, a small clone can synthesize a very toxic protein, producing devastating systemic damage and protean clinical pres...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2006-03-001164

    authors: Merlini G,Stone MJ

    更新日期:2006-10-15 00:00:00

  • A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements.

    abstract::Acute promyelocytic leukemia (APL) is typified by the t(15;17) translocation, which leads to the formation of the PML/RARA fusion gene and predicts a beneficial response to retinoids. However, approximately 10% of all APL cases lack the classic t(15;17). This group includes (1) cases with cryptic PML/RARA gene rearran...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sainty D,Liso V,Cantù-Rajnoldi A,Head D,Mozziconacci MJ,Arnoulet C,Benattar L,Fenu S,Mancini M,Duchayne E,Mahon FX,Gutierrez N,Birg F,Biondi A,Grimwade D,Lafage-Pochitaloff M,Hagemeijer A,Flandrin G,Groupe Français d'

    更新日期:2000-08-15 00:00:00

  • A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion.

    abstract::Human alpha2-antiplasmin (alpha2AP), also known as alpha2-plasmin inhibitor, is the major inhibitor of the proteolytic enzyme plasmin that digests fibrin. There are 2 N-terminal forms of alpha2AP that circulate in human plasma: a 464-residue protein with Met as the N-terminus, Met-alpha2AP, and a 452-residue version w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4240

    authors: Lee KN,Jackson KW,Christiansen VJ,Chung KH,McKee PA

    更新日期:2004-05-15 00:00:00

  • Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-cell formation in primates.

    abstract::To test the in vivo cooperativity between interleukin-3 (IL-3) and erythropoietin (Epo) in stimulating erythropoiesis and hemoglobin F (HbF) production in primates, we administered recombinant human IL-3 and recombinant human Epo to baboons and macaques. The effect of these treatments was assessed by serial bone marro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Umemura T,al-Khatti A,Donahue RE,Papayannopoulou T,Stamatoyannopoulos G

    更新日期:1989-10-01 00:00:00

  • Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.

    abstract::In an attempt to decrease the relapse rate after bone marrow transplantation (BMT) for advanced acute leukemia, we initiated studies using 131I-labeled anti-CD45 antibody (BC8) to deliver radiation specifically to hematopoietic tissues, followed by a standard transplant preparative regimen. Biodistribution studies wer...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Matthews DC,Appelbaum FR,Eary JF,Fisher DR,Durack LD,Bush SA,Hui TE,Martin PJ,Mitchell D,Press OW

    更新日期:1995-02-15 00:00:00

  • Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP.

    abstract::Immune thrombocytopenias are usually associated with normal or increased numbers of megakaryocytes in the marrow. Therefore, the mechanism(s) responsible for the destruction of circulating platelets may not affect megakaryocytes in the same way. One of the possibilities which could account for the differential effect ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stahl CP,Zucker-Franklin D,McDonald TP

    更新日期:1986-02-01 00:00:00

  • Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma.

    abstract::The origin of low-grade mucosa-associated lymphoid tissue (MALT)-type B-cell lymphoma is still unclear. Using a novel two-step procedure, we have sequenced the Ig VH genes expressed by cells from four patients with gastric low-grade MALT-type lymphoma. The nucleotide sequences of the complementarity determining region...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Qin Y,Greiner A,Trunk MJ,Schmausser B,Ott MM,Müller-Hermelink HK

    更新日期:1995-11-01 00:00:00

  • Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor.

    abstract::Constitutively active JAK2V617F and thrombopoietin receptor (TpoR) W515L/K mutants are major determinants of human myeloproliferative neoplasms (MPNs). We show that a TpoRW515 mutation (W515A), which we detected in 2 myelofibrosis patients, and the Delta5TpoR active mutant, where the juxtamembrane R/KW(515)QFP motif i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-10-183558

    authors: Pecquet C,Staerk J,Chaligné R,Goss V,Lee KA,Zhang X,Rush J,Van Hees J,Poirel HA,Scheiff JM,Vainchenker W,Giraudier S,Polakiewicz RD,Constantinescu SN

    更新日期:2010-02-04 00:00:00

  • Association of tissue factor pathway inhibitor with human umbilical vein endothelial cells.

    abstract::Tissue factor pathway inhibitor (TFPI) is a serine protease inhibitor of the extrinsic coagulation system, synthesized in endothelial cells, which has recently been shown to play an important role in the regulation of activated coagulation factors at the endothelial cell surface. In the present study we investigated t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hansen JB,Olsen R,Webster P

    更新日期:1997-11-01 00:00:00

  • Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.

    abstract::Atypical hemolytic uremic syndrome (aHUS) is a severe renal disease that is associated with defective complement regulation caused by multiple factors. We previously described the deficiency of factor H-related proteins CFHR1 and CFHR3 as predisposing factor for aHUS. Here we identify in an extended cohort of 147 aHUS...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-109876

    authors: Józsi M,Licht C,Strobel S,Zipfel SL,Richter H,Heinen S,Zipfel PF,Skerka C

    更新日期:2008-02-01 00:00:00

  • Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.

    abstract::Doxorubicin, bleomycin, vinblastine sulfate, and dacarbazine (ABVD) is associated with severe toxicity in older patients, particularly from bleomycin-induced lung toxicity (BLT). Therefore, using bleomycin has been questioned in older Hodgkin lymphoma (HL) patients, especially in early-stage HL. We therefore analyzed ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2015-11-681064

    authors: Böll B,Goergen H,Behringer K,Bröckelmann PJ,Hitz F,Kerkhoff A,Greil R,von Tresckow B,Eichenauer DA,Bürkle C,Borchmann S,Fuchs M,Diehl V,Engert A,Borchmann P

    更新日期:2016-05-05 00:00:00

  • Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment.

    abstract::Activated platelets release their granule content in a concentrated fashion at sites of injury. We examined whether ectopically expressed factor VIII in developing megakaryocytes would be stored in alpha-granules and whether its release from circulating platelets would effectively ameliorate bleeding in a factor VIIIn...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1519

    authors: Yarovoi HV,Kufrin D,Eslin DE,Thornton MA,Haberichter SL,Shi Q,Zhu H,Camire R,Fakharzadeh SS,Kowalska MA,Wilcox DA,Sachais BS,Montgomery RR,Poncz M

    更新日期:2003-12-01 00:00:00

  • Regulation of early human hematopoietic (BFU-E and CFU-GEMM) progenitor cells in vitro by interleukin 1-induced fibroblast-conditioned medium.

    abstract::Stimulators of human erythroid burst-forming units (BFU-E) and multipotential colony-forming cells (CFU-GEMM) can be produced by a number of different cell types. A product of human peripheral blood monocytes, interleukin 1 (IL-1), was evaluated for its ability to stimulate fibroblast cultures to produce stimulators o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zucali JR,Broxmeyer HE,Dinarello CA,Gross MA,Weiner RS

    更新日期:1987-01-01 00:00:00

  • All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship.

    abstract::All-trans retinoic acid induces leukemic cells from patients with acute promyelocytic leukemia (M3) to differentiate in vitro to mature granulocytes which express the CD15 antigen and are capable of respiratory burst function. Of 35 M3 samples, only one failed to respond. In eight cases, we compared the efficacy of tw...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chomienne C,Ballerini P,Balitrand N,Daniel MT,Fenaux P,Castaigne S,Degos L

    更新日期:1990-11-01 00:00:00

  • A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

    abstract::This study investigated the immunogenicity of Wilms tumor gene product 1 (WT1)-peptide vaccination in WT1-expressing acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients without curative treatment option. Vaccination consisted of granulocyte-macrophage colony-stimulating factor subcutaneously days ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-202598

    authors: Keilholz U,Letsch A,Busse A,Asemissen AM,Bauer S,Blau IW,Hofmann WK,Uharek L,Thiel E,Scheibenbogen C

    更新日期:2009-06-25 00:00:00

  • Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia.

    abstract::The anti-CD33 antibody calicheamicinconjugate gemtuzumab ozogamicin (GO) was used to treat 16 patients with acute promyelocytic leukemia (APL) who had relapsed at the molecular level. Of these patients, 8 were experiencing a first, 5 a second, 2 a third, and 1 a fourth relapse. GO was administered at 6 mg/m2 for 2 dos...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-04-1550

    authors: Lo-Coco F,Cimino G,Breccia M,Noguera NI,Diverio D,Finolezzi E,Pogliani EM,Di Bona E,Micalizzi C,Kropp M,Venditti A,Tafuri A,Mandelli F

    更新日期:2004-10-01 00:00:00

  • Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia.

    abstract::We investigated the effects of interleukin-4 (IL-4) on the survival of leukemic and normal B-cell progenitors cultured on bone marrow stroma. IL-4 (at 100 U/mL) was cytotoxic in 16 of 21 cases of B-lineage acute lymphoblastic leukemia, causing reductions in CD19+ cell numbers that ranged from 50% to greater than 99% (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Manabe A,Coustan-Smith E,Kumagai M,Behm FG,Raimondi SC,Pui CH,Campana D

    更新日期:1994-04-01 00:00:00

  • Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation.

    abstract::Interleukin-25 (IL-25) is a recently described T helper 2 (T(H)2) cell-derived cytokine that belongs to the IL-17 family and induces the production of IL-4, IL-5, and IL-13 from an unidentified non-T-cell population. Here, we show that mast cells are also potent IL-25-producing cells. When bone marrow-derived mast cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2817

    authors: Ikeda K,Nakajima H,Suzuki K,Kagami S,Hirose K,Suto A,Saito Y,Iwamoto I

    更新日期:2003-05-01 00:00:00

  • Platelet endothelial cell adhesion molecule 1 deficiency misguides venous thrombus resolution.

    abstract::Platelet endothelial cell adhesion molecule 1 (PECAM-1) is involved in leukocyte migration and angiogenesis, which are key components of venous thrombus resolution. This study investigated the effect of PECAM-1 deficiency on thrombus resolution in FVB/n mice and the extent to which levels of soluble PECAM-1 (sPECAM-1)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-04-499558

    authors: Kellermair J,Redwan B,Alias S,Jabkowski J,Panzenboeck A,Kellermair L,Winter MP,Weltermann A,Lang IM

    更新日期:2013-11-07 00:00:00

  • N-Ras(G12D) induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene.

    abstract::AML1-ETO (AE) is a fusion product of t(8;21) observed in 40% French-American-British M2 type of acute myeloid leukemia (AML). Clinical data suggest that Ras mutation is a frequent cooperating event in t(8;21) AML. Whether constitutively active Ras promotes leukemogenesis on the t(8;21) background has not been demonstr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-264119

    authors: Chou FS,Wunderlich M,Griesinger A,Mulloy JC

    更新日期:2011-02-17 00:00:00

  • HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells.

    abstract::Histone deacetylase 6 (HDAC6) is a heat shock protein 90 (hsp90) deacetylase. Treatment with pan-HDAC inhibitors or depletion of HDAC6 by siRNA induces hyperacetylation and inhibits ATP binding and chaperone function of hsp90. Treatment with 17-allylamino-demothoxy geldanamycin (17-AAG) also inhibits ATP binding and c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-03-143644

    authors: Rao R,Fiskus W,Yang Y,Lee P,Joshi R,Fernandez P,Mandawat A,Atadja P,Bradner JE,Bhalla K

    更新日期:2008-09-01 00:00:00

  • Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.

    abstract::The complex of the serine protease factor IX (FIX) and its cofactor, factor VIII (FVIII), is crucial for propagation of the intrinsic coagulation cascade. Absence of either factor leads to hemophilia, a disabling disorder marked by excessive hemorrhage after minor trauma. FVIII is the more commonly affected protein, e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-353672

    authors: Milanov P,Ivanciu L,Abriss D,Quade-Lyssy P,Miesbach W,Alesci S,Tonn T,Grez M,Seifried E,Schüttrumpf J

    更新日期:2012-01-12 00:00:00

  • Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia.

    abstract::Mutations in the kinase domain (KD) of BCR-ABL are the most prevalent mechanism of acquired imatinib resistance in patients with chronic myeloid leukemia (CML). Here we examine predisposing factors underlying acquisition of KD mutations, evidence for acquisition of mutations before and during therapy, and whether the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-066936

    authors: O'Hare T,Eide CA,Deininger MW

    更新日期:2007-10-01 00:00:00

  • Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma.

    abstract::Regulatory T (Treg) cells contribute to immune evasion by malignancies. To investigate their importance in non-Hodgkin lymphoma (NHL), we enumerated Treg cells in peripheral blood mononuclear cells (PBMCs) and involved tissues from 30 patients. CD25(+)FoxP3(+)CD127(low)CD4(+) Treg cells were increased markedly in PBMC...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-105395

    authors: Mittal S,Marshall NA,Duncan L,Culligan DJ,Barker RN,Vickers MA

    更新日期:2008-06-01 00:00:00

  • Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.

    abstract::In a previous multicenter phase III trial comparing peripheral blood stem cell transplantation (PBSCT) to bone marrow transplantation (BMT) from HLA-matched related donors, we found no statistically significant difference in the cumulative incidence of clinical extensive chronic graft-versus-host disease (GVHD) in the...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2002-01-0011

    authors: Flowers ME,Parker PM,Johnston LJ,Matos AV,Storer B,Bensinger WI,Storb R,Appelbaum FR,Forman SJ,Blume KG,Martin PJ

    更新日期:2002-07-15 00:00:00

  • The identification and characterization of zebrafish hematopoietic stem cells.

    abstract::HSCs are defined by their ability to self-renew and maintain hematopoiesis throughout the lifespan of an organism. The optical clarity of their embryos and the ease of genetic manipulation make the zebrafish (Danio rerio) an excellent model for studying hematopoiesis. Using flow cytometry, we identified 2 populations ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-327403

    authors: Ma D,Zhang J,Lin HF,Italiano J,Handin RI

    更新日期:2011-07-14 00:00:00

  • The osmotic fragility of erythrocytes after prolonged liquid storage and after reinfusion.

    abstract::Although it is recognized that red cells lose membrane during storage, estimation of the osmotic fragility of erythrocytes has not previously proven to be a useful measurement of the storage lesion. Erythrocytes from blood stored in CPD-A2 were found to have a markedly increased osmotic fragility. A major portion of t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Beutler E,Kuhl W,West C

    更新日期:1982-06-01 00:00:00

  • Changing the differentiation program of hematopoietic cells: retinoic acid-induced shift of eosinophil-committed cells to neutrophils.

    abstract::The mechanisms by which hematopoietic progenitor cells become lineage-committed remain poorly understood. A cloned subline of the AML14 cell line (AML14.3D10) that spontaneously differentiates to eosinophilic myelocytes in the absence of cytokine stimulation was obtained by limiting dilution. This subline exhibits aug...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Paul CC,Mahrer S,Tolbert M,Elbert BL,Wong I,Ackerman SJ,Baumann MA

    更新日期:1995-11-15 00:00:00

  • Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice.

    abstract::It has been shown previously that multilineage human hematopoiesis is maintained within human fetal bone marrow (BM) fragments implanted into severe combined immunodeficient (SCID) mice. We describe here an application of this animal model, the SCID-hu mouse, to the study of human myeloid leukemias. BM cells from 8 pa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Namikawa R,Ueda R,Kyoizumi S

    更新日期:1993-10-15 00:00:00

  • Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels.

    abstract::Congenital deficiency in coagulation factor XIII is a rare autosomal recessive bleeding disorder. Although the defect was characterized over 30 years ago, little is known about the molecular basis of the disorder. Here, we show two novel point mutations in the gene of the A-subunit of factor XIII in the genetically is...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mikkola H,Syrjälä M,Rasi V,Vahtera E,Hämäläinen E,Peltonen L,Palotie A

    更新日期:1994-07-15 00:00:00